Two Sigma Advisers »

Lava Therapeutics Nv shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $57k 32k 1.80
2024-03-31 $56k 17k 3.33

More positions owned by Two Sigma Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Uber Technologies (UBER)
Mastercard Incorporated Cl A (MA)
Pfizer (PFE)
Crowdstrike Hldgs Cl A (CRWD)
Micron Technology (MU)
Abbott Laboratories (ABT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Two Sigma Advisers

Top funds holding Lava Therapeutics Nv

Redmile Group
Bruce & Co
Sphera Funds Management
Two Sigma Investments
Pathway Financial Advisors
Falcon Edge Capital
Susquehanna International
Pnc Financial Services
Tang Capital Management
Two Sigma Advisers
Citadel Advisors
Virtu Financial
Morgan Stanley
Engineers Gate Manager
Geode Capital Management

View all funds holding Lava Therapeutics Nv